Skip to the main content
Project

Global Access in Action

Global Access in Action, a project of the Berkman Klein Center for Internet & Society at Harvard University, conducts action-oriented research into access to lifesaving medicines, and alternative incentives for the development of medical treatments for underserved populations. Improving access and promoting socially beneficial innovation are key strategies for combatting the communicable disease burden that disproportionately harms the world’s most vulnerable populations.


Our Work 13

Apr 27, 2020 @ 12:00 PM

[Virtual] Borderless COVID-19, Restricted Vaccines

Video & Podcast: Assessing the global pricing of vaccines and treatments

Video & Podcast: Borderless Covid-19 confronts restricted vaccine

Oct 23, 2018 @ 8:00 AM

Drug Pricing Policies in the United States and Globally

From Development to Delivery

Join us for a one-day conference exploring the current pharmaceutical pricing landscape. This event will bring together leaders from the pharmaceutical industry, policymakers,…

Oct 16, 2018 @ 11:00 AM

Achieving Equitable Access to Vaccines

From Policies to Provisions

Julia Barnes-Weise discusses the challenges of achieving equitable access to vaccines in preparation for and in times of outbreak and CEPI’s approach in working towards its…

News
Sep 15, 2017

Ruth Okediji joins Global Access in Action as Co-Director

Ruth Okediji, a leading scholar in international intellectual property law and global economic regulation, joined Global Access in Action as Co-Director.

Jul 30, 2017 @ 12:00 PM

Trump's ‘America First’ Trade Agenda

What It Means for Access to Medicines

US foreign policy regulates, incentivizes and subsidizes access to medicines for patients around the world, from intellectual property protection and market access commitments in…

Jul 23, 2017 @ 12:00 PM

Global Data Flows and the Implications for Health Access in Developing Countries

featuring HLS Professor Mark Wu

What types of policies concerning cross-border data flows should developing countries be adopting and advocating to safeguard their interests, particularly with respect to health…

Event
Jun 26, 2017 @ 12:00 PM

Expanding Access to Medicines and Promoting Innovation

A Practical Approach

Global Access in Action: Conversations in Global Health, Innovation, & the Digital World

News
Jun 15, 2017

Expanding Access to Medicines and Promoting Innovation: A Practical Approach

Pharma companies can increase access to medicines and spur new R&D by replicating industry best practices, Harvard team argues in new paper

Jun 11, 2017 @ 12:00 PM

Potential Uses of Miniature Spectrometers to Mitigate the Health Crisis in Developing Countries

featuring HLS Professor William Fisher

Global Access in Action: Conversations in Global Health, Innovation, & the Digital World

News
Jun 13, 2016

Berkman Center & Harvard Global Health Institute Host Conference on Access to Medicines & Innovation

Today, the Harvard Global Health Institute and the Berkman Center for Internet & Society will bring together more than sixty leaders from the pharmaceutical industry, foundations,…

News
Jul 10, 2015

Berkman Initiative Spotlights Lessons from Ebola outbreak

Global Access in Action (GAiA), an initiative of the Berkman Center for Internet & Society at Harvard, is hosting a workshop today to explore lessons from the recent Ebola…

Aug 1, 2014

New Berkman Center initiative, Global Access in Action, hosts inaugural workshop on access to medicines in developing countries

Global Access in Action (GAiA), a new initiative of the Berkman Center for Internet & Society at Harvard, is hosting a workshop today to assess promising but understudied…

Mar 27, 2014

Global Access in Action Submits Comments to the Office of the U.S. Trade Representative regarding PITAC

Berkman Center Faculty Director Terry Fisher, with Quentin Palfrey of WilmerHale and Sara Boettiger of Global Access in Action, submitted comments today responding to a Requests…


Community 06

Harvard Public Health Review

COVID-19 Vaccines and the Case for a New Global Health Diplomacy

Padmashree Gehl Sampath outlines the benefits of global collaboration in the manufacture of the COVID-19 vaccine, as well as the disconnect between…

May 20, 2021
Harvard Law Today

Waiving COVID vaccine patent rights? It’s complicated

Terry Fisher and Ruth Okediji propose changes to bolster global south’s ability to produce pharmaceuticals

May 4, 2021
The Conversation

South African case study sheds light on how vaccine manufacturing can be developed

Padmashree Gehl Sampath and her co-author provide an overview of a case study on financing and manufacturing the COVID-19 vaccine

Apr 11, 2021
Medium

Dealing with an epidemic

Preparing for the worst and hoping for the best

Examining the unique socio-economic characteristics that affect how Small Islands States cope with health epidemics.

Aug 8, 2018

People 06

Point of Contact

Team